Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Other Non-Current Liabilities (2025 - 2026)

Updated

Adaptin Bio's Other Non-Current Liabilities was $551,269 in Q2 2026, unchanged from $551,269 a year earlier and unchanged from the prior quarter.

Analysis

Adaptin Bio (APTN) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends

From Q1 2025 onward, Adaptin Bio has reported Other Non-Current Liabilities for 6 quarters.

  • Per Business Quant data, APTN's Other Non-Current Liabilities in the three quarters before Q2 2026 was $551,269 (Q1 2026), $551,269 (Q4 2025) and $551,269 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 551,269.00
Mar 31, 2026 551,269.00
Dec 31, 2025 551,269.00
Sep 30, 2025 551,269.00
Jun 30, 2025 551,269.00
Mar 31, 2025 551,269.00
API Access

Adaptin Bio Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=APTN&period=max&api_key=YOUR_API_KEY